Louisiana State Employees Retirement System Gilead Sciences, Inc. Transaction History

Louisiana State Employees Retirement System

  • $5.33 Billion
  • Q3 2024

A detailed history of Louisiana State Employees Retirement System transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Louisiana State Employees Retirement System holds 165,100 shares of GILD stock, worth $15.6 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
165,100
Previous 169,500 2.6%
Holding current value
$15.6 Million
Previous $11.6 Million 19.0%
% of portfolio
0.26%
Previous 0.23%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024
SELL
$66.59 - $83.99 $292,996 - $369,556
-4,400 Reduced 2.6%
165,100 $13.8 Million
Q2 2024

Jul 24, 2024
SELL
$63.15 - $72.88 $44,205 - $51,016
-700 Reduced 0.41%
169,500 $11.6 Million
Q1 2024

Apr 23, 2024
SELL
$71.58 - $87.29 $293,478 - $357,889
-4,100 Reduced 2.35%
170,200 $12.5 Million
Q4 2023

Jan 29, 2024
SELL
$73.27 - $83.09 $102,578 - $116,326
-1,400 Reduced 0.8%
174,300 $14.1 Million
Q3 2023

Oct 17, 2023
BUY
$73.94 - $80.67 $1.52 Million - $1.65 Million
20,500 Added 13.21%
175,700 $13.2 Million
Q2 2023

Jul 18, 2023
BUY
$76.01 - $86.7 $912,120 - $1.04 Million
12,000 Added 8.38%
155,200 $12 Million
Q1 2023

Apr 19, 2023
SELL
$77.31 - $88.08 $7,731 - $8,808
-100 Reduced 0.07%
143,200 $11.9 Million
Q4 2022

Jan 24, 2023
SELL
$62.32 - $89.47 $267,976 - $384,721
-4,300 Reduced 2.91%
143,300 $12.3 Million
Q3 2022

Oct 19, 2022
BUY
$59.54 - $68.01 $59,540 - $68,010
1,000 Added 0.68%
147,600 $9.11 Million
Q2 2022

Jul 20, 2022
BUY
$57.72 - $65.01 $28,860 - $32,505
500 Added 0.34%
146,600 $9.11 Million
Q1 2022

Apr 22, 2022
BUY
$57.92 - $72.58 $46,336 - $58,064
800 Added 0.55%
146,100 $9.29 Million
Q4 2021

Jan 14, 2022
BUY
$64.88 - $73.64 $155,712 - $176,736
2,400 Added 1.68%
145,300 $10.6 Million
Q3 2021

Oct 12, 2021
SELL
$67.69 - $73.03 $13,538 - $14,606
-200 Reduced 0.14%
142,900 $9.98 Million
Q2 2021

Jul 16, 2021
BUY
$63.47 - $69.35 $12,694 - $13,869
200 Added 0.14%
143,100 $9.85 Million
Q1 2021

Apr 14, 2021
BUY
$60.0 - $68.46 $612,000 - $698,291
10,200 Added 7.69%
142,900 $9.24 Million
Q4 2020

Jan 11, 2021
BUY
$56.65 - $64.55 $3.91 Million - $4.45 Million
69,000 Added 108.32%
132,700 $7.73 Million
Q3 2020

Oct 19, 2020
BUY
$62.1 - $78.08 $608,580 - $765,184
9,800 Added 18.18%
63,700 $4.03 Million
Q2 2020

Jul 13, 2020
BUY
$72.34 - $84.0 $7,234 - $8,400
100 Added 0.19%
53,900 $4.15 Million
Q1 2020

Apr 13, 2020
SELL
$62.63 - $80.22 $394,569 - $505,386
-6,300 Reduced 10.48%
53,800 $4.02 Million
Q4 2019

Jan 17, 2020
SELL
$61.62 - $67.78 $49,296 - $54,224
-800 Reduced 1.31%
60,100 $3.91 Million
Q3 2019

Oct 24, 2019
SELL
$62.51 - $69.0 $181,279 - $200,100
-2,900 Reduced 4.55%
60,900 $3.86 Million
Q2 2019

Jul 15, 2019
SELL
$61.87 - $69.38 $216,545 - $242,829
-3,500 Reduced 5.2%
63,800 $4.23 Million
Q1 2019

Apr 15, 2019
SELL
$62.53 - $70.05 $37,518 - $42,030
-600 Reduced 0.88%
67,300 $4.38 Million
Q4 2018

Jan 14, 2019
SELL
$60.54 - $79.0 $484,320 - $632,000
-8,000 Reduced 10.54%
67,900 $4.25 Million
Q3 2018

Oct 16, 2018
SELL
$71.28 - $78.92 $42,768 - $47,352
-600 Reduced 0.78%
75,900 $5.86 Million
Q2 2018

Jul 18, 2018
SELL
$64.88 - $75.68 $227,079 - $264,880
-3,500 Reduced 4.38%
76,500 $5.42 Million
Q1 2018

Apr 18, 2018
BUY
$72.84 - $88.8 $65,556 - $79,920
900 Added 1.14%
80,000 $6.03 Million
Q4 2017

Jan 16, 2018
SELL
$71.15 - $83.52 $170,760 - $200,448
-2,400 Reduced 2.94%
79,100 $5.67 Million
Q3 2017

Oct 16, 2017
BUY
$72.11 - $85.47 $5.88 Million - $6.97 Million
81,500
81,500 $6.6 Million

Others Institutions Holding GILD

# of Institutions
1,926
Shares Held
992M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Louisiana State Employees Retirement System Portfolio

Follow Louisiana State Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Louisiana State Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Louisiana State Employees Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email